Tetra Radar · FDA Approvals · Decision date
lorundrostat: FDA decision date
Mineralys Therapeutics, Inc. (MLYS) · 22 December 2026
The FDA accepted the NDA submission and provided us with a Prescription Drug User Fee Act (PDUFA) target date of December 22, 2026 for lorundrostat.
Source: 10-Q of 4 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.